Weekend reads: Editors who publish in their own journals; a crackdown on paper mills; oncologist violates university policies in developing treatment

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured: A sting involving hydroxychloroquine, push scooters, and COVID-19 A home … Continue reading Weekend reads: Editors who publish in their own journals; a crackdown on paper mills; oncologist violates university policies in developing treatment

Spider researcher uses legal threats, public records requests to prevent retractions

The case of Jonathan Pruitt, a spider researcher suspected of fabricating data in potentially dozens of studies, keeps getting weirder.  Pruitt, according to our count, now has six retractions. Currently associate professor and Canada 150 Research Chair at McMaster University in Hamilton, Ontario, he made a name for himself by providing other scientists with field … Continue reading Spider researcher uses legal threats, public records requests to prevent retractions

Did a journal retract your paper on homeopathy? Meet the journal that will publish your complaint

A homeopathy journal that Elsevier dropped in the wake of concerns about excessive self-citation appears to have carved out a new niche for itself: self-pity.  In 2016, Homeopathy lost its slot on Thomson Reuters’s (now Clarivate’s)  influential journal rankings list after an analysis found that more than 70% of citations in the papers it published … Continue reading Did a journal retract your paper on homeopathy? Meet the journal that will publish your complaint

Hydroxychloroquine, push-scooters, and COVID-19: A journal gets stung, and swiftly retracts

This may be the scientific publishing version of “the operation was a success, but the patient died.” The retraction of a Trojan horse paper on the novel coronavirus has called into question the validity of another article in the same journal which found that hydroxychloroquine is effective against Covid-19.  The sting article, “SARS-CoV-2 was Unexpectedly … Continue reading Hydroxychloroquine, push-scooters, and COVID-19: A journal gets stung, and swiftly retracts

Study rating attractiveness of women with endometriosis is not yet retracted

Despite media reports announcing the retraction of a much-criticized study of whether women with endometriosis were more attractive than other women, the study has yet to be retracted by the journal. Last week, several news outlets, picking up on a story in The Guardian, said the study, first published in 2012 in Fertility and Sterility, … Continue reading Study rating attractiveness of women with endometriosis is not yet retracted

Paper earns expression of concern after author blames COVID-19 restrictions for not being able to find raw data

The pandemic ate our data.  A group of researchers in India whose findings in a 2015 paper evidently looked too good to be true have received an expression of concern because they claim Covid-19 restrictions have made it impossible to recover their raw data. The article, “Possible role of P-glycoprotein in the neuroprotective mechanism of … Continue reading Paper earns expression of concern after author blames COVID-19 restrictions for not being able to find raw data

A retraction and a retraction request as Twitter users call out sexism, fat-shaming, and racism

Overweight people are more dishonest, women with endometriosis are more attractive, and affirmative action needs to stop: Papers with these three conclusions have come under intense scrutiny on social media in recent days, with at least one retracted.  First up, a study — widely criticized for being sexist — which claimed to find that Women … Continue reading A retraction and a retraction request as Twitter users call out sexism, fat-shaming, and racism

Journal editor breaks protocol to thank an anonymous whistleblower

As Retraction Watch readers may recall, we’ve been highlighting — and championing — the work of anonymous whistleblowers throughout the 10-year history of the blog. Our support for such anonymity, however, is not universally shared.  In 2011, for example, in our column at Lab Times (unfortunately no longer online), we wrote:

A bitter aftertaste: Legal threats, alleged poisoning muddy the waters for a trial of a tea to treat malaria

Xavier Argemi first heard the claim that tea made from artemisia herbs could be useful in the treatment of malaria from a TV documentary in 2017. The documentary, featuring Lucile Cornet-Vernet, the director of the La Maison de l’Artemisia, a non-profit organization that grows artemisia and promotes its use in centers across Africa, focused on … Continue reading A bitter aftertaste: Legal threats, alleged poisoning muddy the waters for a trial of a tea to treat malaria

Ten takeaways from ten years at Retraction Watch

As we celebrate our tenth birthday and look forward to our second decade, we thought it would be a good time to take stock and reflect on some lessons we — and others — have learned. Retractions are more common than we — or anyone else — thought they were. Two decades ago, journals were … Continue reading Ten takeaways from ten years at Retraction Watch